- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2008
- Public Summary Document (PSD) November 2008 PBAC Meeting - PDF
Hydromorphone hydrochloride – November 2008
Hydromorphone hydrochloride, prolonged release tablets, 8 mg, 16 mg, 32 mg, 64 mg, Jurnista®, November 2008
Last updated
25 March 2009
